Christopher A Maxwell

12PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsMedical biotechnology not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 15, 2026
Cabergoline Suppresses Postpartum Breast Cancer by Enhancing Mammary Gland Involution in Brca1-Mutant Mice and Is Associated with Reduced Risk in Younger Women.

|May 02, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.

Joanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski

|Apr 09, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe.

Georgina D Barnabas, Tariq A Bhat, Verena Goebeler

|Mar 23, 2024
The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia.

Ali Farrokhi, Tanmaya Atre, Jenna Rever

|Nov 21, 2023
Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia.

Amanda C Lorentzian, Jenna Rever, Enes K Ergin

|Aug 12, 2023
Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease.

Seyed M Rahavi, Maryam Aletaha, Ali Farrokhi

Pageof 2

Frequent Collaborators

6 joint publications

Philipp F Lange

4 joint publications

Gregor S D Reid

3 joint publications

Nina Rolf

3 joint publications

Chinten James Lim